Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Vijaya L, Damaraju"'
Autor:
Vijaya L. Damaraju, Maral Aminpour, Michelle Kuzma, Philip Winter, Jordane Preto, Jack Tuszynski, Alexander B.J. McEwan, Michael B. Sawyer
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 847-858 (2021)
Positron emission tomography (PET) using 2‐deoxy‐2‐[18F]fluoro‐d‐glucose ([18F]FDG), a marker of energy metabolism and cell proliferation, is routinely used in the clinic to assess patient response to chemotherapy and to monitor tumor growt
Externí odkaz:
https://doaj.org/article/0ee71f90bba14c2d88d2155aa4242963
Autor:
Cédric Vrignaud, Mahmoud Mikdar, Romain Duval, Luc Reininger, Vijaya L. Damaraju, Michael Sawyer, Yves Colin, Caroline Le Van Kim, Jean‐Christophe Gelly, Catherine Etchebest, Thierry Peyrard, Slim Azouzi
Publikováno v:
Transfusion. 63:610-618
Autor:
Philippe Gros, Carol E. Cass, Morris J. Robins, Yunshan Peng, Delores Mowles, Normand Groulx, Vijaya L. Damaraju, Jie Cai
Supplementary Figure 1 from Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35420a2c1a15ea102e9d64786a81328a
https://doi.org/10.1158/0008-5472.22375320
https://doi.org/10.1158/0008-5472.22375320
Data from Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells
Autor:
Philippe Gros, Carol E. Cass, Morris J. Robins, Yunshan Peng, Delores Mowles, Normand Groulx, Vijaya L. Damaraju, Jie Cai
To understand the mechanism of cellular resistance to the nucleoside analogue cytarabine (1-β-d-arabinofuranosylcytosine, AraC), two resistant derivatives of the human leukemic line CCRF-CEM were obtained by stepwise selection in different concentra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2c75ff89816a4cf3a98cee8ce68c5c6
https://doi.org/10.1158/0008-5472.c.6497769
https://doi.org/10.1158/0008-5472.c.6497769
Autor:
Philippe Gros, Carol E. Cass, Morris J. Robins, Yunshan Peng, Delores Mowles, Normand Groulx, Vijaya L. Damaraju, Jie Cai
Supplementary Table 1 from Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c237039b567faa26bf2b2ad873fbc7
https://doi.org/10.1158/0008-5472.22375317
https://doi.org/10.1158/0008-5472.22375317
Autor:
Bérengère Koehl, Livia Claude, Karen Reminy, Vanessa Tarer, Véronique Baccini, Marc Romana, Yves Colin‐Aronovicz, Vijaya L. Damaraju, Michael Sawyer, Thierry Peyrard, Maryse Etienne‐Julan, Caroline Le Van Kim, Slim Azouzi, Luc Reininger
Publikováno v:
British journal of haematologyREFERENCES.
Hypoxia-mediated red blood cell (RBC) sickling is central to the pathophysiology of sickle cell disease (SCD). The signalling nucleoside adenosine is thought to play a significant role in this process. This study investigated expression of the erythr
Autor:
Jack A. Tuszynski, Michael B. Sawyer, Vijaya L. Damaraju, Philip Winter, Jordane Preto, Alexander B.J. McEwan, Maral Aminpour, Michelle Kuzma
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 3, Pp 847-858 (2021)
Positron emission tomography (PET) using 2-deoxy-2-[18 F]fluoro-d-glucose ([18 F]FDG), a marker of energy metabolism and cell proliferation, is routinely used in the clinic to assess patient response to chemotherapy and to monitor tumor growth. Treat
Autor:
Florian C. Maier, Anna Schweifer, Vijaya L. Damaraju, Carol E. Cass, Gregory D. Bowden, Walter Ehrlichmann, Manfred Kneilling, Bernd J. Pichler, Friedrich Hammerschmidt, Gerald Reischl
Publikováno v:
Pharmaceuticals, Vol 12, Iss 1, p 31 (2019)
The benefits of PET imaging of tumor hypoxia in patient management has been demonstrated in many examples and with various tracers over the last years. Although, the optimal hypoxia imaging agent has yet to be found, 2-nitroimidazole (azomycin) sugar
Externí odkaz:
https://doaj.org/article/6eea80e75643418a81865cbc411b6abd
Autor:
Sarah F. Cook, Anil A. Joy, Ann Vlahadamis, Karen King, Vijaya L. Damaraju, Avalyn Stanislaus, Larissa J. Vos, Michael B. Sawyer, Judith Meza-Junco, Edith Pituskin, Sanraj Basi, Robert R. Bies, Sambasivarao Damaraju, John R. Mackey
Publikováno v:
Clinical breast cancer. 21(5)
Background Epirubicin is metabolized by uridine glucuronosyltransferase 2B7 (UGT2B7). Patients homozygous for the minor allele (CC) in the UGT2B7 -161 promoter polymorphism have lower clearance and significantly higher rates of leukopenia compared to
Autor:
Vijaya L, Damaraju, Maral, Aminpour, Michelle, Kuzma, Philip, Winter, Jordane, Preto, Jack, Tuszynski, Alexander B J, McEwan, Michael B, Sawyer
Publikováno v:
Clinical and Translational Science
Positron emission tomography (PET) using 2‐deoxy‐2‐[18F]fluoro‐d‐glucose ([18F]FDG), a marker of energy metabolism and cell proliferation, is routinely used in the clinic to assess patient response to chemotherapy and to monitor tumor growt